Home	Fast Track My Amedeo FAQ About	Flying Publisher
Fast Track	FPG #8: Alternative Treatments in Psychiatry FPG #7: Critical Care in Neurology	Free Medical Books

Tuberculosis

Free Subscription Articles published in J Antimicrob Chemother Retrieve available abstracts of 46 articles: HTML format Text format

Single Articles

January 2012
1. MARURI F , Sterling TR, Kaiga AW, Blackman A, et al
   A systematic review of gyrase mutations associated with fluoroquinolone-resistant Mycobacterium tuberculosis and a proposed gyrase numbering system.
   J Antimicrob Chemother. 2012.
   PubMed     Text format     Related articles    Abstract available
   
   
   
   
2. REDDY VM , Dubuisson T, Einck L, Wallis RS, et al
   SQ109 and PNU-100480 interact to kill Mycobacterium tuberculosis in vitro.
   J Antimicrob Chemother. 2012.
   PubMed     Text format     Related articles    Abstract available
   
   
   
   December 2011
3. ABBATE E , Vescovo M, Natiello M, Cufre M, et al
   Successful alternative treatment of extensively drug-resistant tuberculosis in Argentina with a combination of linezolid, moxifloxacin and thioridazine.
   J Antimicrob Chemother. 2011.
   PubMed     Text format     Related articles    Abstract available
   
   
   
   November 2011
4. HUANG TS , Kunin CM, Yan BS, Chen YS, et al
   Susceptibility of Mycobacterium tuberculosis to sulfamethoxazole, trimethoprim and their combination over a 12 year period in Taiwan.
   J Antimicrob Chemother. 2011.
   PubMed     Text format     Related articles    Abstract available
   
   
   
   
5. CHOPRA S , Matsuyama K, Tran T, Malerich JP, et al
   Evaluation of gyrase B as a drug target in Mycobacterium tuberculosis.
   J Antimicrob Chemother. 2011.
   PubMed     Text format     Related articles    Abstract available
   
   
   
   October 2011
6. SALERI N , Dembele SM, Villani P, Carvalho AC, et al
   Systemic exposure to rifampicin in patients with tuberculosis and advanced HIV disease during highly active antiretroviral therapy in Burkina Faso.
   J Antimicrob Chemother. 2011.
   PubMed     Text format     Related articles    Abstract available
   
   
   
   September 2011
7. ZHANG J , Zhu L, Stonier M, Coumbis J, et al
   Determination of rifabutin dosing regimen when administered in combination with ritonavir-boosted atazanavir.
   J Antimicrob Chemother. 2011;66:2075-82.
   PubMed     Text format     Related articles    Abstract available
   
   
   
   July 2011
8. LAI CC , Tan CK, Huang YT, Liao CH, et al
   Fluoroquinolone-resistant tuberculosis at a medical centre in Taiwan, 2005-10.
   J Antimicrob Chemother. 2011.
   PubMed     Text format     Related articles   
   
   
   
   
9. CHEN L , Li N, Liu M, Zhang J, et al
   High prevalence of multidrug-resistant tuberculosis in Zunyi, Guizhou Province of China.
   J Antimicrob Chemother. 2011.
   PubMed     Text format     Related articles   
   
   
   
   
10. REY-JURADO E , Tudo G, Borrell S, Alcaide F, et al
    Impaired fitness of Mycobacterium tuberculosis resistant isolates in a cell culture model of murine macrophages.
    J Antimicrob Chemother. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
11. SHI D , Li L, Zhao Y, Jia Q, et al
    Characteristics of embB mutations in multidrug-resistant Mycobacterium tuberculosis isolates in Henan, China.
    J Antimicrob Chemother. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
12. CREMADES R , Rodriguez JC, Garcia-Pachon E, Galiana A, et al
    Comparison of the bactericidal activity of various fluoroquinolones against Mycobacterium tuberculosis in an in vitro experimental model.
    J Antimicrob Chemother. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    June 2011
13. XU HB , Jiang RH, Li L
    Pulmonary resection for patients with multidrug-resistant tuberculosis: systematic review and meta-analysis.
    J Antimicrob Chemother. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
14. STURDY A , Goodman A, Jose RJ, Loyse A, et al
    Multidrug-resistant tuberculosis (MDR-TB) treatment in the UK: a study of injectable use and toxicity in practice.
    J Antimicrob Chemother. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
15. VAN DEN BOOGAARD J , Semvua HH, van Ingen J, Mwaigwisya S, et al
    Low rate of fluoroquinolone resistance in Mycobacterium tuberculosis isolates from northern Tanzania.
    J Antimicrob Chemother. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
16. GUZMAN JD , Wube A, Evangelopoulos D, Gupta A, et al
    Interaction of N-methyl-2-alkenyl-4-quinolones with ATP-dependent MurE ligase of Mycobacterium tuberculosis: antibacterial activity, molecular docking and inhibition kinetics.
    J Antimicrob Chemother. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    May 2011
17. AHMAD Z , Fraig MM, Pinn ML, Tyagi S, et al
    Effectiveness of tuberculosis chemotherapy correlates with resistance to Mycobacterium tuberculosis infection in animal models.
    J Antimicrob Chemother. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
18. ALMEIDA DA SILVA PE , Palomino JC
    Molecular basis and mechanisms of drug resistance in Mycobacterium tuberculosis: classical and new drugs.
    J Antimicrob Chemother. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    April 2011
19. MENA A , Vazquez P, Castro A, Lopez S, et al
    Clinical experience of raltegravir-containing regimens in HIV-infected patients during rifampicin-containing treatment of tuberculosis.
    J Antimicrob Chemother. 2011;66:951-2.
    PubMed     Text format     Related articles   
    
    
    
    
20. MARTIN A , Paasch F, Docx S, Fissette K, et al
    Multicentre laboratory validation of the colorimetric redox indicator (CRI) assay for the rapid detection of extensively drug-resistant (XDR) Mycobacterium tuberculosis.
    J Antimicrob Chemother. 2011;66:827-33.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
21. SIU GK , Zhang Y, Lau TC, Lau RW, et al
    Mutations outside the rifampicin resistance-determining region associated with rifampicin resistance in Mycobacterium tuberculosis.
    J Antimicrob Chemother. 2011;66:730-3.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
22. INAGAKI T , Yagi T, Ichikawa K, Nakagawa T, et al
    Evaluation of a rapid detection method of clarithromycin resistance genes in Mycobacterium avium complex isolates.
    J Antimicrob Chemother. 2011;66:722-9.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    March 2011
23. ENGSTROM A , Perskvist N, Werngren J, Hoffner SE, et al
    Comparison of clinical isolates and in vitro selected mutants reveals that tlyA is not a sensitive genetic marker for capreomycin resistance in Mycobacterium tuberculosis.
    J Antimicrob Chemother. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
24. BLASCHITZ M , Hasanacevic D, Hufnagl P, Hasenberger P, et al
    Real-time PCR for single-nucleotide polymorphism detection in the 16S rRNA gene as an indicator for extensive drug resistance in Mycobacterium tuberculosis.
    J Antimicrob Chemother. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
25. CAMPANERUT PA , Ghiraldi LD, Spositto FL, Sato DN, et al
    Rapid detection of resistance to pyrazinamide in Mycobacterium tuberculosis using the resazurin microtitre assay.
    J Antimicrob Chemother. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    January 2011
26. SYRE H , Grewal H
    Isoniazid and rifampicin resistance-associated mutations in Mycobacterium tuberculosis isolates from Yangon, Myanmar: implications for rapid molecular testing-authors' response.
    J Antimicrob Chemother. 2011.
    PubMed     Text format     Related articles   
    
    
    
    December 2010
27. KOSER CU , Summers DK, Archer JA
    Comment on: Isoniazid and rifampicin resistance-associated mutations in Mycobacterium tuberculosis isolates from Yangon, Myanmar: implications for rapid molecular testing.
    J Antimicrob Chemother. 2010.
    PubMed     Text format     Related articles   
    
    
    
    November 2010
28. COLEMAN D , Waddell SJ, Mitchison DA
    Effects of low incubation temperatures on the bactericidal activity of anti-tuberculosis drugs.
    J Antimicrob Chemother. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
29. LAMORDE M , Byakika-Kibwika P, Okaba-Kayom V, Ryan M, et al
    Nevirapine pharmacokinetics when initiated at 200 mg or 400 mg daily in HIV-1 and tuberculosis co-infected Ugandan adults on rifampicin.
    J Antimicrob Chemother. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    October 2010
30. DE STEENWINKEL JE , de Knegt GJ, Ten Kate MT, van Belkum A, et al
    Time-kill kinetics of anti-tuberculosis drugs, and emergence of resistance, in relation to metabolic activity of Mycobacterium tuberculosis.
    J Antimicrob Chemother. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    September 2010
31. NISA S , Blokpoel MC, Robertson BD, Tyndall JD, et al
    Targeting the chromosome partitioning protein ParA in tuberculosis drug discovery.
    J Antimicrob Chemother. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    August 2010
32. TUDO G , Rey E, Borrell S, Alcaide F, et al
    Characterization of mutations in streptomycin-resistant Mycobacterium tuberculosis clinical isolates in the area of Barcelona.
    J Antimicrob Chemother. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
33. GUZMAN JD , Gupta A, Evangelopoulos D, Basavannacharya C, et al
    Anti-tubercular screening of natural products from Colombian plants: 3-methoxynordomesticine, an inhibitor of MurE ligase of Mycobacterium tuberculosis.
    J Antimicrob Chemother. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
34. AHMAD Z , Pinn ML, Nuermberger EL, Peloquin CA, et al
    The potent bactericidal activity of streptomycin in the guinea pig model of tuberculosis ceases due to the presence of persisters.
    J Antimicrob Chemother. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    June 2010
35. CHANG KC , Yew WW, Chan RC
    Rapid assays for fluoroquinolone resistance in Mycobacterium tuberculosis: a systematic review and meta-analysis.
    J Antimicrob Chemother. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
36. KANA BD , Mizrahi V, Gordhan BG
    Depletion of resuscitation-promoting factors has limited impact on the drug susceptibility of Mycobacterium tuberculosis.
    J Antimicrob Chemother. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
37. SHARMA S , Kumar M, Sharma S, Nargotra A, et al
    Piperine as an inhibitor of Rv1258c, a putative multidrug efflux pump of Mycobacterium tuberculosis.
    J Antimicrob Chemother. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    April 2010
38. DARBY CM , Nathan CF
    Killing of non-replicating Mycobacterium tuberculosis by 8-hydroxyquinoline.
    J Antimicrob Chemother. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
39. PLINKE C , Cox HS, Zarkua N, Karimovich HA, et al
    embCAB sequence variation among ethambutol-resistant Mycobacterium tuberculosis isolates without embB306 mutation.
    J Antimicrob Chemother. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
40. SHI W , Zhang Y
    PhoY2 but not PhoY1 is the PhoU homologue involved in persisters in Mycobacterium tuberculosis.
    J Antimicrob Chemother. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    March 2010
41. CHEN L , Gan X, Li N, Wang J, et al
    rpoB gene mutation profile in rifampicin-resistant Mycobacterium tuberculosis clinical isolates from Guizhou, one of the highest incidence rate regions in China.
    J Antimicrob Chemother. 2010.
    PubMed     Text format     Related articles   
    
    
    
    
42. ANGEBY KA , Jureen P, Giske CG, Chryssanthou E, et al
    Wild-type MIC distributions of four fluoroquinolones active against Mycobacterium tuberculosis in relation to current critical concentrations and available pharmacokinetic and pharmacodynamic data.
    J Antimicrob Chemother. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    February 2010
43. EVANS J , Segal H
    Novel multiplex allele-specific PCR assays for the detection of resistance to second-line drugs in Mycobacterium tuberculosis.
    J Antimicrob Chemother. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
44. ANGER HA , Dworkin F, Sharma S, Munsiff SS, et al
    Linezolid use for treatment of multidrug-resistant and extensively drug-resistant tuberculosis, New York City, 2000-06.
    J Antimicrob Chemother. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    January 2010
45. AHMAD Z , Nuermberger EL, Tasneen R, Pinn ML, et al
    Comparison of the 'Denver regimen' against acute tuberculosis in the mouse and guinea pig.
    J Antimicrob Chemother. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
46. SYRE H , Ovreas K, Grewal HM
    Determination of the susceptibility of Mycobacterium tuberculosis to pyrazinamide in liquid and solid media assessed by a colorimetric nitrate reductase assay.
    J Antimicrob Chemother. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    
    

Thank you for your interest in scientific medicine.

Amedeo is a Flying Publisher website.    Design: